Share on LinkedInShare on LinkedIn

ARTICLE · 26 AUGUST 2025

The Czech Republic v Diag Human SE & Josef Stava [2025] EWCA Civ 998

Jincheng Tongda & Neal
Jincheng Tongda & Neal
Contributor
Jincheng Tongda & Neal

Jincheng Tongda & Neal

JINCHENG TONGDA & NEAL (JT&N) was founded in Beijing in 1992. JT&N has distinguished itself as a...

View firm profile
Explore more from Jincheng Tongda & Neal

In a recent decision, the English Court of Appeal (Civil Division) addressed whether the setting aside of an arbitral award against one claimant, Diag Human SE ("Diag SE")...

GlobalLitigation, Mediation & Arbitration

Introduction

In a recent decision, the English Court of Appeal (Civil Division) addressed whether the setting aside of an arbitral award against one claimant, Diag Human SE (“Diag SE”), had any impact on the award granted to a co-claimant, Mr.Josef Stava (“Stava”). The case originated under the Bilateral Investment Treaty (“BIT”) between Switzerland and the Czech Republic (“CZR”).

On 7 May 2025, the Court delivered its judgment in three appeals brought by CZR. These appeals challenged an arbitral award under sections 67 and 68 of the Arbitration Act 1996 (the “Act”), granting approximately US$350 million plus interest to Stava and Diag SE.

CZR's challenge to the award in favour of Stava was unsuccessful. However, its challenge against the award in favour of Diag SE succeeded. The Court found that Diag SE did not meet the criteria to quality as an investor under the BIT, and therefore, the arbitral tribunal lacked substantive jurisdiction over the dispute

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from